• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD RESURFACING FEMORAL HEAD 46MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITH & NEPHEW ORTHOPAEDICS LTD RESURFACING FEMORAL HEAD 46MM; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING Back to Search Results
Catalog Number 74121146
Device Problems Compatibility Problem (2960); Loosening of Implant Not Related to Bone-Ingrowth (4002)
Patient Problems Failure of Implant (1924); Pain (1994); Arthralgia (2355); Inadequate Osseointegration (2646)
Event Date 07/01/2019
Event Type  Injury  
Event Description
It was reported that, after a bhr construct had been implanted in the left hip on (b)(6) 2011, the patient presented pain, fluid under pressure from effusion, and aseptic loosening.A revision surgery was performed on (b)(6) 2019 to treat the adverse event.The patient outcome is unknown.
 
Manufacturer Narrative
H3, h6: it was reported that left hip revision surgery was performed.As of today, the implanted devices, all of which were used in treatment, and additional information have been requested for this complaint but have not become available.A review of the complaint history for the bhr cup, bhr head was performed using batch numbers in search of similar recurring reports for the products during their lifetimes.Similar complaints have been identified for the head and cup.However, as the device is no longer sold, no action is to be taken.In the absence of the actual devices, the production records were reviewed for the devices reportedly involved in this incident.Review of manufacturing records did not reveal any waivers, concessions, manufacturing or material abnormalities that could have contributed to this issue.Review of the product's instructions for use found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed.No additional risks were identified as result of the reported event.The available medical documents were reviewed.Without status post implantation and pre-revision x-rays, supporting lab/pathology results, and/or the analysis of the explanted components; the root cause of the femoral implant loosening cannot be confirmed and it cannot be concluded that the femoral loosening was associated with a mal-performance of the implant.The patient impact beyond the revision, and expected transient post-op convalescence period cannot be determined.Without return of the actual devices or further information we cannot further investigate or confirm the details supplied in this complaint, and our investigation remains inconclusive.If the products or additional information become available in the future, this case will be reopened.No preventative or corrective action has been initiated as a result of this investigation.
 
Manufacturer Narrative
H9: the concomitant product (74120152 / lot # 10cw26211) was also subject to a recall action under z-2746-2015.H3, h6.It was reported that left hip revision surgery was performed due to femoral aseptic loosening in conjunction with fluid under pressure from effusion in the hip joint and pain.As of today, the implanted devices, all of which were used in treatment, and additional information have been requested for this complaint but have not become available.A review of the complaint history for the bhr cup and head was performed using batch numbers in search of similar recurring reports for the products during their lifetimes.Similar complaints have been identified for both parts and this will continue to be monitored via routine trending, however it should be noted that devices of this size are no longer sold.In the absence of the actual devices, the production records were reviewed for the devices reportedly involved in this incident.Review of manufacturing records did not reveal any waivers, concessions, manufacturing or material abnormalities that could have contributed to this issue.Review of the product ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed.No additional risks were identified as result of the reported event.A review of historic escalation actions related to the products and similar complaint events was performed.Following the review, prior applicable escalation actions were identified and confirmed to reduce associated risks as far as possible.No further escalation actions are required.The available medical documents were reviewed.With the limited information provided, the clinical root cause of the femoral implant loosening cannot be confirmed and it cannot be concluded that the femoral loosening was associated with a mal-performance of the implant.The patient impact beyond the revision, and expected transient post-op convalescence period cannot be determined.It is noted 3-months s/p left tha, ¿she is doing well.¿ without return of the actual devices or further information we cannot further investigate or confirm the details supplied in this complaint, and our investigation remains inconclusive.If the products or additional information become available in the future, this case will be reopened.No preventative or corrective action has been initiated as a result of this investigation.
 
Manufacturer Narrative
H10: additional information: a4: patient weight.B7: other relevant history.D10: concomitant medical products h11 ¿ corrected data.A1: patient identifier.B5: describe event or problem.E1: initial reporter name and address.G1: contact office.G1: phone number.H6: evaluation codes.
 
Event Description
It was reported that, after undergoing left hip resurfacing (bhr) on (b)(6) 2011 due to degenerative joint disease in conjunction with hip dysplasia, the patient suffered femoral aseptic loosening in conjunction with fluid under pressure from effusion in the hip joint and pain.These complications were treated by performing a revision surgery on (b)(6) 2019, in which the bhr head was explanted, and a smith and nephew tha system was placed instead.Patient's current health status is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESURFACING FEMORAL HEAD 46MM
Type of Device
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING
Manufacturer (Section D)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house
spa park
leamington spa warwickshire
UK 
Manufacturer (Section G)
SMITH & NEPHEW ORTHOPAEDICS LTD
aurora house
spa park
leamington spa, warwickshire
UK  
Manufacturer Contact
holly topping
7000 west william cannon drive
spa park
austin, TX 78735
5123913905
MDR Report Key10440218
MDR Text Key204007069
Report Number3005975929-2020-00313
Device Sequence Number1
Product Code NXT
UDI-Device Identifier03596010502780
UDI-Public3596010502780
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P040033
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer,Health Professional,Company Representative
Reporter Occupation Other
Remedial Action Recall
Type of Report Initial,Followup,Followup,Followup
Report Date 08/25/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/21/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/30/2015
Device Catalogue Number74121146
Device Lot Number10DW26927
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received08/22/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured04/30/2010
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction NumberZ-2745-2015
Patient Sequence Number1
Treatment
ACTLR CUP52MM (PN:74120152,LN:10CW26211)
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age57 YR
Patient SexFemale
Patient Weight84 KG
-
-